Consumer advocates come out against Woodcock . . .

Former FDAer Doubts Woodcock Will Be FDA Chief, Others Not So Sure

By Beth Wang / January 28, 2021 at 8:02 PM
FDA drug center director Janet Woodcock has been pegged as a potential front-runner for the full-time commissioner position ever since she was named acting agency chief by President Joe Biden. But Marc Scheineson, partner at Alston & Bird and a former FDA associate commissioner, says that by putting her in the acting role, it’s unlikely the Biden administration will nominate her for the permanent role, as agency heads typically come from outside the agency’s career force, even though she might...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.